India's biggest drugmaker Sun Pharmaceutical Industries on Monday posted a 92.7% jump in consolidated net profit to ₹1,714 crore for the quarter ended March. Total income grew by 6.8% to ₹7,599 crore. Further, for the entire fiscal 2015-16, the company reported a net profit of ₹4,716 crore, up by 3.88% from ₹4,539 crore in the previous fiscal.